TOFANEC TAB

About

TOFANEC TAB is a targeted synthetic disease-modifying antirheumatic drug (tsDMARD) belonging to the class of Janus kinase (JAK) inhibitors. Its active ingredient, likely Tofacitinib, works by selectively inhibiting the activity of JAK enzymes, which are crucial in the signaling pathways of various cytokines and growth factors involved in inflammation and immune responses. By modulating these pathways, TOFANEC TAB helps to reduce inflammation, alleviate pain, and slow the progression of autoimmune diseases. It is a potent immunosuppressant used when conventional therapies have been insufficient or poorly tolerated, offering a novel mechanism of action for chronic inflammatory conditions.

Uses

• Treatment of moderate to severe rheumatoid arthritis
• Management of active psoriatic arthritis
• Treatment of moderate to severe ulcerative colitis
• Management of active ankylosing spondylitis

Directions For Use

Take orally as directed by your physician, usually once or twice daily, with or without food.

Benefits

• Significantly reduces inflammation and pain
• Improves joint function and mobility
• Slows the progression of joint damage
• Reduces disease activity in autoimmune conditions
• Offers a targeted approach to immune modulation
• Improves overall quality of life for patients

Side Effects

• Upper respiratory tract infections
• Headache
• Diarrhea
• Nausea
• Increased cholesterol levels
• Hypertension
• Herpes zoster (shingles)
• Serious infections (e.g., pneumonia, tuberculosis)
• Blood clots (e.g., DVT, PE)
• Malignancy (e.g., lymphoma, lung cancer)
• Anemia
• Neutropenia

Safety Measures

• Alcohol - May increase the risk of liver-related side effects; moderate consumption is advised, and discuss with your doctor.
• Pregnancy - Avoid use during pregnancy due to potential for fetal harm; effective contraception is required.
• Breastfeeding - Avoid use during breastfeeding as it is excreted in breast milk and may harm the infant.
• Liver - Use with caution; dose adjustment is necessary in patients with moderate to severe liver impairment.
• Kidney - Use with caution; dose adjustment is necessary in patients with moderate to severe kidney impairment.
• Lung - Increased risk of serious infections, including opportunistic infections and interstitial lung disease; monitor closely.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.